arrow
A

Alan Pestronk

washington university
H指数:94
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study
2026-02-060
PRE
High-Density Lipoprotein-Associated Cholesterol Abnormalities in a Clinical Outcomes Study of Dysferlin-Deficient Limb–Girdle Muscular Dystrophy Type R2

高密度脂蛋白相关胆固醇异常在dysferlin缺乏型肢带型肌营养不良R2型临床结局研究中的表现

2025-08-150
OA
Biallelic variants in COQ7 cause distal hereditary motor neuropathy with upper motor neuron signs

COQ7的双等位基因变异导致远端遗传性运动神经病伴上运动神经元体征

BRAIN
IF11.7
2023-05-1212
PRE
Water T2 could predict functional decline in patients with dysferlinopathy
2022-09-048
OA
Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
2022-06-0713
OA
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale
2021-02-2622
OA
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
2020-07-09372
OAAI
Loss- or Gain-of-Function Mutations in ACOX1 Cause Axonal Loss via Different Mechanisms
NEURON
IF15
2020-05-0175
OAAI
Assessment of disease progression in dysferlinopathy: A 1-year cohort study
2019-01-2922
OAAI
Congenital Titinopathy: Comprehensive characterization and pathogenic insights
2018-07-2793
OAAI
Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials
2018-05-0781
OAAI